SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-017178
Filing Date
2016-04-29
Accepted
2016-04-29 16:22:59
Documents
10
Period of Report
2016-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bioc-8k_20160429.htm 8-K 36753
2 EX-4.1 bioc-ex41_8.htm EX-4.1 93181
3 EX-5.1 bioc-ex51_7.htm EX-5.1 22116
4 EX-10.1 bioc-ex101_11.htm EX-10.1 55752
5 EX-10.2 bioc-ex102_9.htm EX-10.2 205482
6 EX-99.1 bioc-ex991_64.htm EX-99.1 11433
7 GRAPHIC gamfs3ir5ypy000001.jpg GRAPHIC 24621
8 GRAPHIC gamfs3ir5ypy000004.jpg GRAPHIC 2721
9 GRAPHIC g4yc4efnskry000001.jpg GRAPHIC 2360
10 GRAPHIC gfs4r2kl4rcs000001.jpg GRAPHIC 7292
  Complete submission text file 0001564590-16-017178.txt   477370
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 330757995 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 161606931
SIC: 8071 Services-Medical Laboratories